Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.
Meldi K, Qin T, Buchi F, Droin N, Sotzen J, Micol JB, Selimoglu-Buet D, Masala E, Allione B, Gioia D, Poloni A, Lunghi M, Solary E, Abdel-Wahab O, Santini V, Figueroa ME.
Meldi K, et al. Among authors: sotzen j.
J Clin Invest. 2015 May;125(5):1857-72. doi: 10.1172/JCI78752. Epub 2015 Mar 30.
J Clin Invest. 2015.
PMID: 25822018
Free PMC article.
Clinical Trial.